Okay, I had Recursion on when they were 9, 10. They did an equity offering. The stock got clobbered. It’s been down.
Amidst the AI boom transforming various sectors, Recursion Pharmaceuticals (NASDAQ: RXRX), a previously beaten-down ...
Abstract: In recent years, the spotlight of research in the adaptive learning era has turned toward distributed adaptive filtering algorithms for sparse systems over ...